Clinical Protocol and Data Management
临床方案和数据管理
基本信息
- 批准号:9755225
- 负责人:
- 金额:$ 9.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAmendmentAreaAwarenessCancer CenterCancer Center Support GrantCaringCatchment AreaChildClinicalClinical DataClinical ManagementClinical ProtocolsClinical ResearchClinical TrialsDataData Base ManagementData ReportingDevelopmentDiseaseEducationEnrollmentEnsureFrequenciesGuidelinesIndustryMalignant NeoplasmsMedical centerMedidataMissionMonitorMonitoring Clinical TrialsNCI Center for Cancer ResearchNational Clinical Trials NetworkNebraskaOffice ManagementPediatric Oncology GroupPhasePopulationPopulation SciencesProceduresProcessProtocols documentationRegulationReportingResearchResearch PersonnelResearch SupportResourcesReview CommitteeRural PopulationSafetySerious Adverse EventSiteSystemTimeTraining and EducationUniversitiesWomananticancer researchcancer carecancer clinical trialcancer therapydata managementimprovedinvestigator-initiated trialmembermetropolitanparticipant safetyprogramsprotocol developmentquality assurancerecruitresearch studyscreeningunderserved minority
项目摘要
Project Summary/Abstract: Clinical Protocol and Data Management (CPDM)
The Office for Cancer Clinical Research (OCCR), previously referred to as the Centralized Protocol Data
Management Unit (CPDMU), is the centralized office that supports clinical cancer research in the Fred and
Pamela Buffett Cancer Center (FPBCC) at the University of Nebraska Medical Center (UNMC). The OCCR
provides centralized support for investigator-initiated trials (IIT), NCI National Clinical Trials Network and
cooperative group trials (Main Member of Alliance, Children's Oncology Group, NRG) multi-institutional
consortium trials (BIG10 Cancer Consortium, ACCRU) and industry-sponsored studies. The mission of the
OCCR is to assist with the planning, development, conduct, quality assurance, monitoring and compliance of
with regulatory agency requirements for clinical trials involving cancer treatments and care, and to provide
regulatory support for cancer-related population science studies as well. The OCCR assures the highest
quality of research and adherence to relevant regulations by primary upfront coordination of the study and
ongoing review of research compliance. The OCCR is a resource within the FPBCC to provide investigators
support for all cancer-related clinical research. It is composed of disease-oriented teams (DOT's) that
coordinate study management activities (including screening subjects, coordination of treatment and care, and
collecting and recording study data), as well as the regulatory management teams responsible for submitting
and maintaining all regulatory documents and applications. The OCCR provides investigators with support and
study data management, as well as protocol development, monitoring for cooperative group studies, and
liaison with federal and industry sponsors and regulatory bodies. The OCCR provides resource support to the
FPBCC Scientific Review Committee (SRC), the Data Safety Monitoring Committee (DSMC), and the Audit
Committee (AC). The OCCR manages the clinical trials management system (CPDM database) which houses
protocol data necessary for planning, reporting and internal oversight, as well as eCRF development and study
data reporting in C3D and MediData RAVE. The FPBCC OCCR has been active in NCI initiatives regarding
the Clinical Trial Reporting Program (CTRP) and has been an early adopter of C3D and Medidata Rave.
项目摘要/摘要:临床协议和数据管理(CPDM)
癌症临床研究办公室(OCCR),以前称为集中协议数据
管理部门(CPDMU),是支持Fred和Fred临床癌症研究的集中办事处
内布拉斯加州大学医学中心(UNMC)的帕梅拉·巴菲特癌症中心(FPBCC)。 OCCR
为研究人员发起的试验(IIT),NCI国家临床试验网络和
合作小组试验(NRG儿童肿瘤学集团联盟的主要成员)多机构
财团试验(BIG10癌症联盟,ACCRU)和行业赞助的研究。任务
OCCR将协助计划,开发,行为,质量保证,监控和遵守
有监管机构对涉及癌症治疗和护理的临床试验的要求,并提供
对癌症相关人群科学研究的监管支持。 OCCR确保最高
通过研究的主要前期协调和遵守相关法规的质量
正在进行的研究合规性审查。 OCCR是FPBCC中的资源,可为调查人员提供
支持所有与癌症相关的临床研究。它由面向疾病的团队(DOT)组成
协调研究管理活动(包括筛查对象,治疗和护理协调以及
收集和记录研究数据)以及负责提交的监管管理团队
并维护所有监管文件和应用。 OCCR为调查人员提供了支持和
研究数据管理以及协议开发,监控合作小组研究以及
与联邦和行业赞助商以及监管机构联络。 OCCR为
FPBCC科学审查委员会(SRC),数据安全监测委员会(DSMC)和审计
委员会(AC)。 OCCR管理临床试验管理系统(CPDM数据库)
计划,报告和内部监督以及ECRF开发和研究所需的协议数据
C3D和Medidata狂欢中的数据报告。 FPBCC OCCR一直活跃于NCI计划
临床试验报告计划(CTRP)一直是C3D和Medidata Rave的早期采用者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Apar Kishor Ganti其他文献
Apar Kishor Ganti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Apar Kishor Ganti', 18)}}的其他基金
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer
MUC5AC在促进非小细胞肺癌中枢神经系统转移中的作用
- 批准号:
10618916 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer
MUC5AC在促进非小细胞肺癌中枢神经系统转移中的作用
- 批准号:
9883472 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer
MUC5AC在促进非小细胞肺癌中枢神经系统转移中的作用
- 批准号:
10454778 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
相似国自然基金
基加利修正案背景下我国建筑部门的协同减排效益及路径研究
- 批准号:72204017
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基加利修正案背景下我国建筑部门的协同减排效益及路径研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Clinical Protocol, Data Management and Informatics Shared Resource
临床方案、数据管理和信息学共享资源
- 批准号:
8180659 - 财政年份:2010
- 资助金额:
$ 9.36万 - 项目类别: